Rege-Cambrin G - Search Results

1

Epcr 23 bp insertion in a patient with severe progressive arterial disease: a dominant loss of function mutant in conditions of increased APC request?

Zecchina G, Bosio S, Brusa E, Rege-Cambrin G, Camaschella C. Zecchina G, et al. Br J Haematol. 2002 Dec;119(3):881-2. doi: 10.1046/j.1365-2141.2002.03870_6.x. Br J Haematol. 2002. PMID: 12437679 Free article. No abstract available.

2

Molecular characterization of thalassemia intermedia in Italy.

Camaschella C, Saglio G, Serra A, Guerrasio A, Bertero T, Rege-Cambrin G, Loi A, Pirastu M. Camaschella C, et al. Birth Defects Orig Artic Ser. 1987;23(5A):111-6. Birth Defects Orig Artic Ser. 1987. PMID: 3689891 No abstract available.

3

Molecular studies on sickle cell anemia in Sicily: preliminary results.

Bertero T, Camaschella C, Rege Cambrin G, Serra A, Giubellino C, Amione C, Gottardi E, Saglio G. Bertero T, et al. Haematologica. 1984 Sep-Oct;69(5):513-20. Haematologica. 1984. PMID: 6094318 No abstract available.

4

Italian type of deletional hereditary persistence of fetal hemoglobin.

Saglio G, Camaschella C, Serra A, Bertero T, Rege Cambrin G, Guerrasio A, Mazza U, Izzo P, Terragni F, Giglioni B, et al. Saglio G, et al. Blood. 1986 Sep;68(3):646-51. Blood. 1986. PMID: 2427137 Free article.

5

CALR-positive myeloproliferative disorder in a patient with Ph-positive chronic myeloid leukemia in durable treatment-free remission: a case report.

Dogliotti I, Fava C, Serra A, Gottardi E, Daraio F, Carnuccio F, Giugliano E, Bocchia M, Saglio G, Rege-Cambrin G. Dogliotti I, et al. Stem Cell Investig. 2017 Jun 23;4:57. doi: 10.21037/sci.2017.06.02. eCollection 2017. Stem Cell Investig. 2017. PMID: 28725653 Free PMC article.

6

Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemia.

Saglio G, Morotti A, Mattioli G, Messa E, Giugliano E, Volpe G, Rege-Cambrin G, Cilloni D. Saglio G, et al. Ann N Y Acad Sci. 2004 Dec;1028:423-31. doi: 10.1196/annals.1322.050. Ann N Y Acad Sci. 2004. PMID: 15650267 Review.

7

Update on emerging treatments for chronic myeloid leukemia.

Fava C, Morotti A, Dogliotti I, Saglio G, Rege-Cambrin G. Fava C, et al. Expert Opin Emerg Drugs. 2015 Jun;20(2):183-96. doi: 10.1517/14728214.2015.1031217. Epub 2015 Mar 31. Expert Opin Emerg Drugs. 2015. PMID: 25826695 Review.

8

New therapeutic approaches and prognostic factors in chronic myeloid leukemia.

Saglio G, Ulisciani S, Bosa M, Cilloni D, Rege-Cambrin G. Saglio G, et al. Leuk Lymphoma. 2008 Apr;49(4):625-8. doi: 10.1080/10428190801896210. Leuk Lymphoma. 2008. PMID: 18398722 Review.

9

Second-generation tyrosine kinase inhibitors can induce complete molecular response in Ph-positive acute lymphoblastic leukemia after allogeneic stem cell transplant.

Fava C, Rege-Cambrin G, Busca A, Gottardi E, Daraio F, Saglio G. Fava C, et al. Clin Lymphoma Myeloma Leuk. 2013 Sep;13 Suppl 2:S272-5. doi: 10.1016/j.clml.2013.05.017. Clin Lymphoma Myeloma Leuk. 2013. PMID: 24290212 No abstract available.

10

NF-kB inhibition as a strategy to enhance etoposide-induced apoptosis in K562 cell line.

Morotti A, Cilloni D, Pautasso M, Messa F, Arruga F, Defilippi I, Carturan S, Catalano R, Rosso V, Chiarenza A, Taulli R, Bracco E, Rege-Cambrin G, Gottardi E, Saglio G. Morotti A, et al. Am J Hematol. 2006 Dec;81(12):938-45. doi: 10.1002/ajh.20732. Am J Hematol. 2006. PMID: 16960866 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters